Cargando…
Bacterial surface properties influence the activity of the TAT-RasGAP(317-326) antimicrobial peptide
Antibiotic resistance is an increasing threat for public health, underscoring the need for new antibacterial agents. Antimicrobial peptides (AMPs) represent an alternative to classical antibiotics. TAT-RasGAP(317-326) is a recently described AMP effective against a broad range of bacteria, but littl...
Autores principales: | Georgieva, Maria, Heinonen, Tytti, Vitale, Alessandra, Hargraves, Simone, Causevic, Senka, Pillonel, Trestan, Eberl, Leo, Widmann, Christian, Jacquier, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365389/ https://www.ncbi.nlm.nih.gov/pubmed/34430812 http://dx.doi.org/10.1016/j.isci.2021.102923 |
Ejemplares similares
-
The EnvZ/OmpR Two-Component System Regulates the Antimicrobial Activity of TAT-RasGAP(317-326) and the Collateral Sensitivity to Other Antibacterial Agents
por: Georgieva, Maria, et al.
Publicado: (2022) -
The Anticancer Peptide TAT-RasGAP(317−326) Exerts Broad Antimicrobial Activity
por: Heulot, Mathieu, et al.
Publicado: (2017) -
Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers
por: Chevalier, Nadja, et al.
Publicado: (2015) -
The TAT-RasGAP(317-326) anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner
por: Heulot, Mathieu, et al.
Publicado: (2016) -
Revisiting G3BP1 as a RasGAP Binding Protein: Sensitization of Tumor Cells to Chemotherapy by the RasGAP 317–326 Sequence Does Not Involve G3BP1
por: Annibaldi, Alessandro, et al.
Publicado: (2011)